The Influence of Fish Consumption on Polyunsaturated Fatty Acid (PUFA) Status
NCT03765580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49
Last updated 2018-12-05
Summary
Polyunsaturated fatty acids (PUFA) are important for health, for example for the immune system, heart health and the brain. PUFA are found in fish, nuts and oils; including these foods in the diet provides the body with PUFA. The body can also produce some PUFA in a series of steps. It has been found that genetics influences the levels of PUFA produced in the body. This study will investigate whether fish consumption influences PUFA status in women of childbearing age when accounting for FADS genotype by conducting a controlled human intervention study. Participants will be asked to consume none, one or two portions of oily fish per week for 8 weeks and their response in PUFA status measured. This study will also use collected blood, hair, urine and faecal samples collected from the intervention study to explore other biomarkers of fish consumption. The aim of this study is to investigate whether fish consumption influences PUFA status in women of childbearing age when accounting for FADS genotype and to explore the potential of a novel biomarker, using hair MeHg:δ34S values, to accurately predict fish consumption. The study will initially involve providing a buccal swab sample which will investigate genes which are related to fatty acids. The participant will provide a buccal swab sample so that their genotype can be determined. The researcher who will contact the participant once genotype has been determined to arrange a baseline appointment. Participants will attend the Human Intervention Studies Unit at Ulster University, Coleraine once or twice weekly for a period of 8 weeks where they will receive lunch. This lunch will contain either tuna, sardines, or no fish depending on the intervention group you will be allocated to. Examples of lunch time meals they may receive include sandwiches, baked potato or salad which will include the type of fish they have been allocated to receive. Those allocated to the no fish group will receive a fish free alternative lunch. Participants will be asked to continue to follow their normal diet and lifestyle over the intervention period of 8 weeks. All participants will attend a baseline and post intervention appointment where they will have weight, height and body composition measured. Participants will also complete questionnaires to provide medical, lifestyle and dietary information. All participants will be asked to provide a sample of blood, urine, hair and faeces to assess biomarkers of fish consumption at baseline and post intervention appointments. Collected blood, urine, hair and faecal samples will be analysed for biomarkers of fish consumption. Participants will also be asked to return to the Human Intervention Studies Unit (HISU) 8 weeks after the intervention study has been completed (week 16) to provide a third hair sample and complete a Fish Feedback Questionnaire. In the 8 wks following conclusion of the study they will be free to return to their normal diet.
Conditions
- Polyunsaturated Fatty Acid (PUFA) Status
Interventions
- DIETARY_SUPPLEMENT
-
Fish
Lunch containing fish
- OTHER
-
Control
Lunch containing no fish
Sponsors & Collaborators
-
University of Rochester
collaborator OTHER -
Lund University
collaborator OTHER -
Ministry of Health, Republic of Seychelles
collaborator UNKNOWN -
University of Ulster
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-01
- Primary Completion
- 2017-05-31
- Completion
- 2017-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
The Effects of Omega-3 PUFAs on the Infant Microbiome and Immunity
NCT03297801 ·Status: COMPLETED
-
Diet Rich in N-3 Polyunsaturated Fatty Acids in Renal Transplant Recipients
NCT01872455 ·Status: COMPLETED ·Phase: PHASE4
-
N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression
NCT01620502 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega-3 Fatty Acids on Kynurenine Metabolism and Mood
NCT05520437 ·Status: UNKNOWN ·Phase: NA
-
Influence of the Background Diet on Metabolism of Land-based n-3 PUFA
NCT03558776 ·Status: COMPLETED ·Phase: NA
-
Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition
NCT03245749 ·Status: COMPLETED
-
Healthful Seafood Consumption for Sensitive Populations
NCT01123759 ·Status: COMPLETED ·Phase: NA
-
Milk Types and Fish Oil in 9- to 12-Month-Old Infants
NCT00379171 ·Status: COMPLETED ·Phase: NA
-
Effect of Fish Oil on Athlete's Executive Function
NCT04570995 ·Status: TERMINATED ·Phase: NA
-
Polyunsaturated Fatty Acids in Child Nutrition
NCT01487889 ·Status: COMPLETED ·Phase: NA
-
Essential Fatty Acid (EFA) Nutrition 5-Year-Olds Follow-Up Study
NCT01112904 ·Status: COMPLETED
-
Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels
NCT03781557 ·Status: UNKNOWN ·Phase: PHASE4
-
Fish Oil Supplementation in Lactation
NCT00266305 ·Status: COMPLETED ·Phase: NA
-
Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance
NCT02177383 ·Status: COMPLETED ·Phase: NA
-
Essential Fatty Acid (EFA) Nutrition 5-Year-Olds X Section
NCT01112930 ·Status: COMPLETED
-
Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE)
NCT01460680 ·Status: UNKNOWN
-
Essential Fatty Acids for Major Depression
NCT00256412 ·Status: COMPLETED ·Phase: NA
-
The Effects of Efalex Active 50+ on Cognitive Performance, Well-being and Cerebral Hemodynamics in Healthy Older Adults
NCT01185379 ·Status: COMPLETED ·Phase: NA
-
Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
NCT00014027 ·Status: COMPLETED ·Phase: PHASE1
-
Supplementation of Alpha-linolenic Acid (ALA)-Rich Oil in Humans
NCT01317290 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging
NCT04910399 ·Status: COMPLETED ·Phase: NA
-
Diet and Physical Activity Counseling and n3-long Chain (PUFA) Supplementation in Obese Pregnant Women
NCT02574767 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Supplementation on Nutritional Status and Physical Activity of Obese Children
NCT04156971 ·Status: COMPLETED ·Phase: NA
-
ω3 LCPUFAs for Healthy Growth and Development of Infants and Young Children in Southwest Ethiopia
NCT01817634 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.
NCT02346773 ·Status: COMPLETED ·Phase: NA